GNRSU Greenrose Holding Company Inc. (PNK) 0.000001 25 Feb 2026: watch liquidity
The GNRSU stock plunged to USD 0.000001 on 25 Feb 2026, a drop of -99.99933% from the prior close of USD 0.15. This extreme fall on the PNK exchange reflects acute illiquidity and microcap volatility rather than broad sector weakness. Volume was only 145 shares, underscoring trading thinness. We analyze fundamentals, market drivers, and the balance of risks and possible recovery paths for The Greenrose Holding Company Inc. in the United States cannabis sector.
GNRSU stock: Price action and market data
GNRSU stock closed at USD 0.000001 on 25 Feb 2026 after a one‑day move of -99.99933% versus the previous close of USD 0.15. Reported volume was 145 shares, and shares outstanding are 12,853,627. Market cap is effectively USD 13.00, while enterprise value is reported at USD 101,417,768.00, a sign of accounting or reporting distortion versus the tiny equity value.
The low trading volume and the wide gap between recent averages (50/200 day average USD 0.15) point to extreme illiquidity and headline-driven swings rather than orderly price discovery on PNK.
GNRSU stock: Fundamentals and valuation snapshot
Greenrose Holding Company Inc. operates in Healthcare, specifically Drug Manufacturers – Specialty & Generic, and reports EPS of USD 3.10 on trailing measures. The quoted PE ratio is effectively 0.00 after the price collapse, reflecting the disconnect between earnings metrics and equity price. Book value per share is USD 4.30, cash per share is USD 0.56, and current ratio is 0.21, highlighting short-term liquidity stress.
These figures show the company’s accounting earnings are not translating into market valuation because of microcap trading issues, possible corporate events, or investor confidence loss.
GNRSU stock: Technicals, liquidity and trading risk
Technically, GNRSU stock is illiquid: day range was USD 0.000001–0.000001 and average volume data is not available. Such conditions create extreme bid-ask spreads and execution risk for buyers and sellers.
Short-term technical recovery would require renewed buying interest, regulatory clarity, or corporate actions to restore tradability. Until then, expect highly volatile intraday prints and potential difficulty exiting positions.
GNRSU stock: Meyka AI grade and model forecast
Meyka AI rates GNRSU with a score out of 100: Score: 67.06 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade balances the company’s reported earnings quality against market and liquidity risks.
Meyka AI’s forecast model projects a near‑term price of USD 0.00, given current market signals and reported forecasts. That projection implies an implied downside of -100.00% versus the current USD 0.000001. Forecasts are model-based projections and not guarantees.
GNRSU stock: Risks, catalysts and realistic price targets
Primary risks include continued illiquidity on PNK, potential delisting or corporate restructuring, and limited public information flow. Inventory days are high and working capital is negative, which adds operational pressure.
Realistic price targets: a defensive bear target is USD 0.00 if trading halts or shares are cancelled; a cautious recovery scenario assumes renewed interest and a price target near USD 0.10 to USD 0.15 within 12 months, representing a large but plausible rebound if liquidity and corporate signals improve.
GNRSU stock: Sector context and investor view
The Healthcare cannabis segment remains mixed; larger listed peers show clearer revenue paths while microcaps like Greenrose face disproportionate liquidity risk. Sector performance is not directly driving this move; GNRSU’s microcap status on the PNK exchange is the dominant factor.
For investors, GNRSU stock is primarily a liquidity and corporate‑event trade, not a standard sector play. Use position sizing, limit orders, and monitor filings closely before considering exposure.
Final Thoughts
Key takeaways: GNRSU stock sits at USD 0.000001 on 25 Feb 2026 after a -99.99933% intraday collapse; the move reflects illiquidity and microcap trading dynamics more than immediate changes to reported earnings. Financials show EPS USD 3.10 and book value USD 4.30, but market capitalization of USD 13.00 is inconsistent with those metrics and signals market breakdown. Meyka AI rates GNRSU with a score out of 100: 67.06 (Grade B) – HOLD, reflecting mixed fundamentals and outsized market risks. Meyka AI’s forecast model projects USD 0.00, implying downside of -100.00% from the current price; forecasts are model-based projections and not guarantees. Given the thin volume (145 shares) and PNK listing, investors should reassess exposure, set tight limits, and watch corporate filings and any trading notices. For tactical traders, the only plausible recoveries require clear liquidity improvement or corporate actions; otherwise the stock remains a high‑risk microcap.
FAQs
Why did GNRSU stock fall to USD 0.000001?
The plunge reflects extreme illiquidity on PNK, a tiny traded volume of 145 shares, and likely trading or corporate events. Fundamentals do not match the price, so market mechanics and microcap volatility drove the drop.
Is GNRSU stock a buy after the drop?
With market cap at USD 13.00 and thin liquidity, GNRSU stock is high risk. Meyka AI’s grade is B (HOLD). Consider size limits, confirm filings, and expect possible further downside before considering a buy.
What are realistic GNRSU price targets?
A bear outcome is USD 0.00 if trading halts or cancellation occurs. A cautious recovery target is USD 0.10–0.15 if liquidity and corporate clarity return within 12 months.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.